4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-000486
Chief Operating Officer gave up 3,098 shares (to pay taxes)
- Chief Operating Officer acquired 8,952 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2023-12-31 | Option exercise | +8,952 | 54,868 | D: show line 1 in the form | ||
| Cittadine Andrew Chief Operating Officer | 2023-12-31 | Shares withheld for taxes | −3,098 | $0.34 | $1,054 | 51,770 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2023-12-31 | Option exercise · Restricted Stock Units | −8,952 | 91,175 | D: show line 3 in the form |
Loading xslF345X05/rdgdoc.xml…